DSCI Derma Sciences, Inc.

7.00
+0  (0%)
Previous Close 7.00
Open 0.00
Price To book 0.00
Market Cap N/A
Shares 0
Volume 0
Short Ratio 0.00
Av. Daily Volume 435,924

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial stopped early due to lack of effiacy - November 2015
DSC127
Diabetic foot ulcers

Latest News

  1. Why One Analyst Sees Almost 40% Upside in Integra LifeSciences
  2. Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
  3. INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders
  4. SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. - DSCI
  5. INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
  6. Harwood Feffer LLP Announces Investigation of Derma Sciences Inc.
  7. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders -- DSCI
  8. DERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. (DSCI) Over the Proposed Sale of the Company to Integra LifeSciences Holdings Corporation
  9. SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information
  10. Integra LifeSciences Buys Derma Sciences for $204M
  11. DERMA SCIENCES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Integra LifeSciences Holdings Corporation May be Unfair to Shareholders
  12. Company News for January 12, 2017
  13. Blog Coverage Integra Set to Acquire Derma Sciences; Announced Outlook 2017
  14. Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner
  15. Wednesday’s Top Biopharma Movers
  16. Derma Sciences Soars Almost 40% on Buyout by Integra